Ligand to Participate in Upcoming Investor Conferences
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that Todd Davis (Chief Executive Officer) and Tavo Espinoza (Chief Financial Officer) will participate in the following upcoming investor
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Taking a wider view, although not as strong as the last mon
Ligand Pharmaceuticals(LGND.US) Director Sells US$77,713.38 in Common Stock
$Ligand Pharmaceuticals(LGND.US)$ Director Gray Nancy Ryan sold 934 shares of common stock on May 9, 2024 at an average price of $83.2049 for a total value of $77,713.38.Source: Announcement What is s
Ligand Pharmaceuticals(LGND.US) Officer Sells US$1.15 Million in Common Stock
$Ligand Pharmaceuticals(LGND.US)$ Officer Espinoza Octavio sold 13,293 shares of common stock on May 15, 16, 17, 2024 at an average price of $86.2637 for a total value of $1.15 million.Source: Announc
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 446.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 194.71K in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Ligand Pharmaceuticals(LGND.US) Officer Sells US$1.5 Million in Common Stock
$Ligand Pharmaceuticals(LGND.US)$ Officer Korenberg Matthew E sold 17,598 shares of common stock on May 13, 14, 2024 at an average price of $84.9949 for a total value of $1.5 million.Source: Announcem
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 505.15K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144(Amend) | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 290.83K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 1.2 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 434.5K in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Ligand Pharmaceuticals(LGND.US) Officer Sells US$830.45K in Common Stock
$Ligand Pharmaceuticals(LGND.US)$ Officer Reardon Andrew sold 10,000 shares of common stock on May 9, 2024 at an average price of $83.0449 for a total value of $830.45K.Source: Announcement What is st
Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing
Andrew Reardon, Chief Legal Officer, on May 09, 2024, sold 10,000 shares in Ligand Pharmaceuticals (LGND) for $830,449. Following the Form 4 filing with the SEC, Reardon has control over a total of 22
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 830.45K in Common Stocks
SEC FILLINGS DISCLOSED/ May 9, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTICA
10% Of This Ligand Pharmaceuticals Insider's Holdings Were Sold
From what we can see, insiders were net sellers in Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchas
10-Q: Quarterly report
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were slipping late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing around 0.3%. The iShares Biotechnology ETF (IBB
Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views
Ligand Pharmaceuticals (LGND) shares were up nearly 11% in recent trading Wednesday, a day after the company's Q1 adjusted net income and revenue exceeded consensus. The company reported Q1 adjusted e
Earnings Call Summary | Ligand Pharmaceuticals(LGND.US) Q1 2024 Earnings Conference
The following is a summary of the Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Call Transcript:Financial Performance:Ligand Pharmaceuticals reported a Q1 2024 revenue of $31 million com
Ligand Pharmaceuticals Price Target Maintained With a $144.00/Share by HC Wainwright & Co.
Ligand Pharmaceuticals Price Target Maintained With a $144.00/Share by HC Wainwright & Co.